Keywords: abbott, napro, sign, paclitaxel, deal, biotherapeutics, signed

Abbott and NaPro sign paclitaxel deal

Article | 29 July 1999

Print This

Abbott and NaPro BioTherapeutics have signed an agreement worth upto $48 million for the development and commercialization of one or more ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in